Delivery Order SPE2DB22D1017-SPE2DB25FYPVC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $3,562.06. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $7,427.51. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitively awarded, non-set-aside contract executed through AmerisourceBergen's existing pharmaceutical supply vehicle with the federal government. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Progesterone 200 mg capsules (100 count) with a ceiling value of $4,508.52. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside contract vehicle, with an ultimate completion date of August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $5,898.94. This firm fixed-price delivery order is scheduled for ultimate completion by September 22, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $14,441.36 and carries no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $14,885.28. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $2,523.81. This is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and represents fulfillment under AmerisourceBergen's broader pharmaceutical supply framework. The contract carries no set-aside designation, indicating it was awarded through open competition....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $13,427.04. This non-set-aside delivery order is scheduled for ultimate completion on September 19, 2025, with performance conducted from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $1,606.93. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The order is scheduled for completion by August 29, 2025, and will be fulfilled from the vendor's Pennsylvania...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $30,912.13. This firm fixed-price delivery order, which is expected to be completed by August 15, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting the...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPVCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Progesterone 200 mg capsules (100-count) with a ceiling value of $3,750.42. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. That prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to military healthcare programs worldwide. The current order exemplifies the company's role as a critical vendor for federal medical procurement, delivering pharmaceutical products across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/3/25 |